Related references
Note: Only part of the references are listed.Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study
Johannes Goldberg et al.
JOURNAL OF NEUROSURGERY (2019)
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations
Robert Shenkar et al.
STROKE (2017)
Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
Amy Akers et al.
NEUROSURGERY (2017)
Efficacy and safety of oral propranolol for infantile hemangioma in Japan
Tsuyoshi Kaneko et al.
PEDIATRICS INTERNATIONAL (2017)
Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults Mayo Clinic Study of Aging
Kelly D. Flemming et al.
JAMA NEUROLOGY (2017)
Consensus statement for the treatment of infantile haemangiomas with propranolol
Sarah L. Smithson et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2017)
A case of giant fetal intracranial capillary hemangioma cured with propranolol
Sergio Cavalheiro et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)
Propranolol stops progressive multiple cerebral cavernoma in an adult patient
Matthias Reinhard et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Natural history of cavernous malformation: Systematic review and meta-analysis of 25 studies
Shervin Taslimi et al.
NEUROLOGY (2016)
The embryo-placental CD15-positive vasculogenic zones as a source of propranolol-sensitive pediatric vascular tumors
L. Seidmann et al.
PLACENTA (2016)
Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage
Joseph M. Zabramski et al.
WORLD NEUROSURGERY (2016)
Cerebral cavernous malformations: natural history and clinical management
Bradley A. Gross et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Cerebral cavernous malformations: natural history and clinical management
Bradley A. Gross et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation
Christopher C. Gibson et al.
CIRCULATION (2015)
Propranolol for Cerebral Cavernous Angiomatosis: A Magic Bullet
Irene Berti et al.
CLINICAL PEDIATRICS (2014)
Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol
Juliette Miquel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Congestive heart failure with diffuse neonatal hemangiomatosis - case report and literature review
Moshe Dotan et al.
ACTA PAEDIATRICA (2013)
Cavernoma-related epilepsy: Review and recommendations for management - Report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies
Felix Rosenow et al.
EPILEPSIA (2013)
Hemangiomas and propranolol
Jennifer Strahle et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2013)
Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis
Andreas Fischer et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Brainstem Cavernous Malformations: 1390 Surgical Cases from the Literature
Bradley A. Gross et al.
WORLD NEUROSURGERY (2013)
Advances in the Treatment and Outcome of Brainstem Cavernous Malformation Surgery: A Single-Center Case Series of 300 Surgically Treated Patients
Adib A. Abla et al.
NEUROSURGERY (2011)
The natural history of intracranial cavernous malformations
Bradley A. Gross et al.
NEUROSURGICAL FOCUS (2011)
Letter by Filippidis et al Regarding Article, Evaluating Strategies for the Treatment of Cerebral Cavernous Malformations
Aristotelis S. Filippidis et al.
STROKE (2011)
Propranolol Treatment for a Giant Infantile Brain Cavernoma
Maria Moschovi et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling
Joycelyn Wuestehube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells
Sylvie Lamy et al.
VASCULAR PHARMACOLOGY (2010)
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
Amy L. Akers et al.
HUMAN MOLECULAR GENETICS (2009)
Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion
Borhane Annabi et al.
PHARMACOLOGICAL RESEARCH (2009)
Biology of Vascular Malformations of the Brain
Gabrielle G. Leblanc et al.
STROKE (2009)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Histopathology of central nervous system cavernomas
J.-F. Mosnier et al.
NEUROCHIRURGIE (2007)
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
J Gault et al.
STROKE (2005)
Share Paper
